HudsonAlpha launched a pilot study, Hope AD, to see how genetics and lifestyle influence a person’s risk of developing ...

Biogen’s lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why BIIB stock is a hold.

But evidence is building that some vaccines may also lower the risk of Alzheimer’s disease, the most common form of dementia. Most recently, researchers examining health outcomes of a shingles ...

Researchers are looking for 200 healthy adults between 65 and 75 who have a close family member with dementia but who do not ...

The U.S. Food and Drug Administration approved donanemab last July, adding a second treatment to the country’s arsenal against early Alzheimer’s. The first approved drug, lecanemab — sold under the ...

Abu Dhabi has taken a groundbreaking step in personalised healthcare by integrating APOE genetic testing for Alzheimer’s disease into its pharmacogenomics (PGx) reports. This innovative approach ...

Davina McCall said she's still "rebuilding" herself five months on from undergoing surgery to have a colloid cyst, a rare ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

A new study found the shingles vaccination cut older adults’ risk of developing dementia over the next seven years by 20%.

A good night’s sleep isn’t just about the number of hours you log. Getting quality sleep — the kind that leaves you feeling ...

Sometimes, the medicines we take to treat everyday health problems can come with hidden side effects. A new study from the ...

The Siouxland community joined together on Thursday in support of the Alzheimer's Assocation as part of the annual Wine and ...